Wolverine Trading
WST icon

Wolverine Trading’s West Pharmaceutical WST Stock Holding History

Wolverine Trading’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$677K Buy
+2,600
New +$632K ﹤0.01% 3342
2025
Q2 		– Sell
-16,600
Closed -$3.69M – 5702
2025
Q1 		$3.69M Sell
16,600
-5,600
-25% -$1.54M ﹤0.01% 1174
2024
Q4 		$7.3M Sell
22,200
-21,100
-49% -$6.64M 0.01% 964
2024
Q3 		$13.5M Buy
43,300
+20,300
+88% +$6.22M 0.01% 564
2024
Q2 		$7.58M Buy
23,000
+21,400
+1,338% +$7.56M 0.01% 761
2024
Q1 		$633K Buy
+1,600
New +$592K ﹤0.01% 2621
2023
Q4 		– Sell
-800
Closed -$300K – 5333
2023
Q3 		$300K Sell
800
-200
-20% -$77.3K ﹤0.01% 3299
2023
Q2 		$377K Buy
1,000
+100
+11% +$35.7K ﹤0.01% 2873
2023
Q1 		$307K Sell
900
-800
-47% -$234K ﹤0.01% 2987
2022
Q4 		$400K Buy
+1,700
New +$403K ﹤0.01% 2520
2022
Q2 		– Sell
-1,000
Closed -$418K – 5876
2022
Q1 		$418K Sell
1,000
-3,500
-78% -$1.37M ﹤0.01% 3473
2021
Q4 		$2.12M Sell
4,500
-7,000
-61% -$3.01M ﹤0.01% 1835
2021
Q3 		$4.97M Buy
11,500
+1,000
+10% +$422K 0.01% 1302
2021
Q2 		$3.78M Buy
10,500
+1,100
+12% +$363K 0.01% 1395
2021
Q1 		$2.62M Buy
+9,400
New +$2.69M ﹤0.01% 1666
2020
Q4 		– Sell
-900
Closed -$246K – 5582
2020
Q3 		$246K Sell
900
-3,100
-78% -$820K ﹤0.01% 3635
2020
Q2 		$881K Buy
4,000
+400
+11% +$78.6K ﹤0.01% 2134
2020
Q1 		$547K Buy
+3,600
New +$554K ﹤0.01% 2562
2019
Q4 		– Sell
-15,800
Closed -$2.23M – 5301
2019
Q3 		$2.23M Sell
15,800
-6,900
-30% -$950K 0.01% 1366
2019
Q2 		$2.84M Buy
22,700
+1,800
+9% +$212K 0.01% 1273
2019
Q1 		$2.3M Buy
20,900
+17,900
+597% +$1.86M 0.01% 1411
2018
Q4 		$289K Buy
+3,000
New +$326K ﹤0.01% 3241

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Wolverine Trading's WST Position: Q2 2025 in Review

Wolverine Trading sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 7,912 shares — an estimated $1.76M sold.

Wolverine Trading first reported a position in WST in Q2 2016 and held it in 16 quarters. The position peaked at $1.76M in Q1 2025. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • Wolverine Trading reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 7,912 West Pharmaceutical shares in Q2 2025, an estimated $1.76M.
  • Wolverine Trading first reported a position in West Pharmaceutical in Q2 2016 and held it in 16 quarters.
  • Wolverine Trading's West Pharmaceutical position peaked at $1.76M in Q1 2025.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.